In a surprise move, Nigeria has become the first country in Africa to receive the highly sought-after mpox vaccine, leaving many wondering why it was chosen ahead of other nations. The World Health Organisation (WHO) announced that Nigeria received 10,000 doses of the vaccine on Tuesday, courtesy of a donation from the United States government.
But what makes Nigeria so special? Is it the country’s high number of mpox cases, with 786 suspected and 39 confirmed as of 10 August? Or is there another factor at play? Perhaps it’s Nigeria’s strategic location, making it a crucial hub for regional healthcare efforts.
However, it’s worth noting that Nigeria is not even the African country with the highest rate of mpox disease. That distinction belongs to another nation, which has been struggling to contain the outbreak. So, why did Nigeria receive the vaccines first?
As the WHO declares the rise of mpox a public health emergency of international concern, many African countries are still waiting for their turn to receive the vaccine. So, what sets Nigeria apart? Is it the country’s strong healthcare system, its robust infrastructure, or its government’s swift response to the outbreak?
Furthermore, amidst the excitement, it’s crucial to remember the recent controversy surrounding Covid-19 vaccines. Just a short while ago, these vaccines came under intense scrutiny for causing more harm than good, leaving the world reeling from the aftermath. The debate about their safety and efficacy still rages on, with many questioning the rush to vaccinate without adequate testing.
In light of this, it’s essential to approach the mpox vaccine with caution and scepticism. Are we repeating the same mistakes? Have we learned from the Covid-19 experience? Or are we rushing headlong into another potential health crisis?
The answers to these questions remain unclear, but one thing is certain – Nigeria is now at the forefront of Africa’s battle against mpox. But will this move be enough to halt the spread of the virus, or is it just the beginning of a long and challenging journey?
